Human iPS cell-engineered cardiac tissue sheets with cardiomyocytes and vascular cells for cardiac regeneration

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Masumoto, Hidetoshi ^a,b   Ikuno, Takeshi ^a,b   Takeda, Masafumi ^a   Fukushima, Hiroyuki ^a   Marui, Akira ^b   Katayama, Shiori ^a   Shimizu, Tatsuya ^c   Ikeda, Tadashi ^b   Okano, Teruo ^c   Sakata, Ryuzo ^b   Yamashita, Jun K ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; CELL DIFFERENTIATION; CYTOLOGY; ENDOTHELIUM CELL; GENETICS; HEART; HEART MUSCLE CELL; HUMAN; MYOCARDIAL INFARCTION; PATHOLOGY; PLURIPOTENT STEM CELL; RAT; REGENERATION; TISSUE ENGINEERING; TRANSPLANTATION;

ANIMALS; CELL DIFFERENTIATION; ENDOTHELIAL CELLS; HEART; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; RATS; REGENERATION; TISSUE ENGINEERING;

EID: 84925966468     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep06716     Document Type: Article

References (29)

1. World Health Organization (WHO), The global burden of disease: 2004 update. http://www.who.int/healthinfo/global-burden-disease/GBD-report- 2004update-full.pdf (2008) (Date of access: 30/06/2014).
2. Ford, E. S. & Capewell, S. Proportion of the Decline in Cardiovascular Mortality Disease due to Prevention Versus Treatment: Public Health Versus Clinical Care. Annu Rev Public Health 32, 5-22 (2011).
3. Committee for Scientific, A., Sakata, R., Fujii, Y. & Kuwano, H. Thoracic and cardiovascular surgery in Japan during 2009: annual report by the Japanese Association for Thoracic Surgery. Gen Thorac Cardiovasc Surg 59, 636-667 (2011).
4. Anversa, P., Kajstura, J., Rota, M. & Leri, A. Regenerating new heart with stem cells. J Clin Invest 123, 62-70 (2013).
5. Joggerst, S. J. & Hatzopoulos, A. K. Stem cell therapy for cardiac repair: benefits and barriers. Expert Rev Mol Med 11, e20 (2009).
6. Masumoto, H. & Sakata, R. Cardiovascular surgery for realization of regenerative medicine. Gen Thorac Cardiovasc Surg 60, 744-755 (2012).
7. Thomson, J. A. Embryonic Stem Cell Lines Derived from Human Blastocysts. Science 282, 1145-1147 (1998).
8. Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861-872 (2007).
9. Muller-Ehmsen, J. et al. Survival and development of neonatal rat cardiomyocytes transplanted into adult myocardium. J Mol Cell Cardiol 34, 107-116 (2002).
10. Teng, C. J., Luo, J., Chiu, R. C. J. & Shum-Tim, D. Massive mechanical loss of microspheres with direct intramyocardial injection in the beating heart: Implications for cellular cardiomyoplasty. J Thorac Cardiovasc Surg 132, 628-632 (2006).
11. Masumoto, H. et al. Pluripotent stem cell-engineered cell sheets reassembled with defined cardiovascular populations ameliorate reduction in infarct heart function through cardiomyocyte-mediated neovascularization. Stem Cells 30, 1196-1205 (2012).
12. Okano, T., Yamada, N., Sakai, H. & Sakurai, Y. A Novel Recovery-System for Cultured-Cells Using Plasma-Treated Polystyrene Dishes Grafted with Poly(NIsopropylacrylamide). J Biomed Mater Res 27, 1243-1251 (1993).
13. Matsuura, K. et al. Transplantation of cardiac progenitor cells ameliorates cardiac dysfunction after myocardial infarction in mice. J Clin Invest 119, 2204-2217 (2009).
14. Yamashita, J. et al. Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors. Nature 408, 92-96 (2000).
15. Yamashita, J. K. et al. Prospective identification of cardiac progenitors by a novel single cell-based cardiomyocyte induction. FASEB J 19, 1534-+ (2005).
16. Narazaki, G. et al. Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells. Circulation 118, 498-506 (2008).
17. Uosaki, H. et al. Efficient and Scalable Purification of Cardiomyocytes from Human Embryonic and Induced Pluripotent Stem Cells by VCAM1 Surface Expression. PLoS One 6 (2011).
18. Li, R. K., Mickle, D. A., Weisel, R. D., Rao, V. & Jia, Z. Q. Optimal time for cardiomyocyte transplantation to maximize myocardial function after left ventricular injury. Ann Thorac Surg 72, 1957-1963 (2001).
19. Sakakibara, Y. et al. Combined procedure of surgical repair and cell transplantation for left ventricular aneurysm: An experimental study. Circulation 106, I193-I197 (2002).
20. Kawamura, M. et al. Feasibility, safety, and therapeutic efficacy of human induced pluripotent stem cell-derived cardiomyocyte sheets in a porcine ischemic cardiomyopathy model. Circulation 126, S29-37 (2012).
21. Kawamura, M. et al. Enhanced survival of transplanted human induced pluripotent stem cell-derived cardiomyocytes by the combination of cell sheets with the pedicled omental flap technique in a porcine heart. Circulation 128, S87-94 (2013).
22. Madden, L. R. et al. Proangiogenic scaffolds as functional templates for cardiac tissue engineering. Proc Natl Acad Sci U S A 107, 15211-15216 (2010).
23. Don, C. W. & Murry, C. E. Improving survival and efficacy of pluripotent stem cell-derived cardiac grafts. J Cell Mol Med (2013).
24. Sakaguchi, K. et al. In vitro engineering of vascularized tissue surrogates. Sci Rep 3, 1316 (2013).
25. Shiba, Y. et al. Human ES-cell-derived cardiomyocytes electrically couple and suppress arrhythmias in injured hearts. Nature 489, 322-325 (2012).
26. Lee, A. S., Tang, C., Rao, M. S., Weissman, I. L. & Wu, J. C. Tumorigenicity as a clinical hurdle for pluripotent stem cell therapies. Nat Med 19, 998-1004 (2013).
27. Okita, K. et al. A more efficient method to generate integration-free human iPS cells. Nat Methods 8, 409-412 (2011).
28. Koyanagi-Aoi, M. et al. Differentiation-defective phenotypes revealed by largescale analyses of human pluripotent stem cells. Proc Natl Acad Sci U S A (2013).
29. Laflamme, M. A. et al. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol 25, 1015-1024 (2007).